Bocheng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bocheng Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jianfeng Zhang
Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China
4 shared publications Jielong Pang
Department of Emergency Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China
4 shared publications- Jieyun Zhu
International Medical Department, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, P. R. China
3 shared publications Pan Ji
Department of Emergency Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China
3 shared publicationsHongyuan Li
Department of Emergency Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China
2 shared publications- Hongyuan Li
College of Environmental Science & Engineering, Nankai University, Tianjin 300350, China
2 shared publications
Latest Publications
- Open Access
- 28 January 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (3) , e24264
Impact of COVID‐19 on emergency patients in the resuscitation room: A cross‐sectional study
Objective: The purpose of this study was to evaluate the impact of COVID‐19 outbreaks on emergency patients in a resuscitation room in Nanning, China.Methods: A single‐center cross‐sectional retrospective study was conducted in the emergency department of a tertiary public hospital from January 1, 2019, to December 31, 2020, in Nanning, Guangxi, China. We collected the data of patients in the resuscitation room to investigate the number of patients accessing emergency services during the study period. Data in 2020 were compared to the data during the same period in 2019.Results: The number of emergency patients in the resuscitation room during the COVID‐19 pandemic has decreased in intrinsic diseases, extrinsic diseases, and pediatric cases, especially in the early stages of the pandemic. Additionally, the length of stay of emergency patients in the resuscitation room was reduced.Conclusions: The number of emergency patients in the resuscitation room during the pandemic of COVID‐19 in 2020 was reduced compared to that in the same period in 2019 in Nanning, China. This situation shows a serious social problem, which should arouse the attention of the medical profession and the government.
- 28 January 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (3) , e24264
Open AccessImpact of COVID‐19 on emergency patients in the resuscitation room: A cross‐sectional study
Objective: The purpose of this study was to evaluate the impact of COVID‐19 outbreaks on emergency patients in a resuscitation room in Nanning, China.Methods: A single‐center cross‐sectional retrospective study was conducted in the emergency department of a tertiary public hospital from January 1, 2019, to December 31, 2020, in Nanning, Guangxi, China. We collected the data of patients in the resuscitation room to investigate the number of patients accessing emergency services during the study period. Data in 2020 were compared to the data during the same period in 2019.Results: The number of emergency patients in the resuscitation room during the COVID‐19 pandemic has decreased in intrinsic diseases, extrinsic diseases, and pediatric cases, especially in the early stages of the pandemic. Additionally, the length of stay of emergency patients in the resuscitation room was reduced.Conclusions: The number of emergency patients in the resuscitation room during the pandemic of COVID‐19 in 2020 was reduced compared to that in the same period in 2019 in Nanning, China. This situation shows a serious social problem, which should arouse the attention of the medical profession and the government.
- Open Access
- 5 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (5) , e23781
Clinical characteristics of 2,459 severe or critically ill COVID-19 patients
Our study aims to summarize the clinical characteristics of patients with severe or critically ill coronavirus disease 2019 (COVID-19). Five databases were electronically searched to collect studies describing clinical characteristics of severe or critically ill COVID-19 patients and published between January 1, 2020 and April 12, 2020. Three reviewers independently collected the literature, extracted the required data, and assessed the risk of publication bias of the included studies before including the studies in the meta-analysis. A total of 40 studies involving 2459 patients with severe or critically ill COVID-19 patients were included. Meta-analysis showed that a greater proportion of severe or critically COVID-19 patients were male (62.3%), and the 2 main clinical symptoms were fever (87.4%) and cough (66.3%). Other common clinical symptoms included dyspnea (45.3%), chest tightness (37.4%), fatigue (36.6%), and expectoration (31.9%). Minor symptoms included myalgia (19.5%), dizziness (11.5%), headache (11.4%), diarrhea (11.2%), pharyngalgia (11.0%), nausea, and vomiting (5.9%). Most patients showed elevated levels of C-reactive protein (83.5%) and D-dimer (73.3%), lymphopenia (70.3%), and normal leukocyte counts (56.9%). Other findings included abnormal levels of liver function (39.8%), elevated procalcitonin (36.6%), leukocytosis (21.7%), thrombocytopenia (19.0%), and leucopenia (18.2%). Most patients showed acute respiratory distress syndrome (60.8%). Other complications included acute cardiac injury (37.1%), shock (32.0%), and acute kidney injury (22.0%). The most common symptoms of severe or critically ill COVID-19 patients were fever and cough. Most patients showed lymphopenia, elevated levels of C-reactive protein and D-dimer. A large percentage of patients progress to ARDS, acute cardiac injury, acute kidney injury and shock were also common.
- 5 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (5) , e23781
Open AccessClinical characteristics of 2,459 severe or critically ill COVID-19 patients
Our study aims to summarize the clinical characteristics of patients with severe or critically ill coronavirus disease 2019 (COVID-19). Five databases were electronically searched to collect studies describing clinical characteristics of severe or critically ill COVID-19 patients and published between January 1, 2020 and April 12, 2020. Three reviewers independently collected the literature, extracted the required data, and assessed the risk of publication bias of the included studies before including the studies in the meta-analysis. A total of 40 studies involving 2459 patients with severe or critically ill COVID-19 patients were included. Meta-analysis showed that a greater proportion of severe or critically COVID-19 patients were male (62.3%), and the 2 main clinical symptoms were fever (87.4%) and cough (66.3%). Other common clinical symptoms included dyspnea (45.3%), chest tightness (37.4%), fatigue (36.6%), and expectoration (31.9%). Minor symptoms included myalgia (19.5%), dizziness (11.5%), headache (11.4%), diarrhea (11.2%), pharyngalgia (11.0%), nausea, and vomiting (5.9%). Most patients showed elevated levels of C-reactive protein (83.5%) and D-dimer (73.3%), lymphopenia (70.3%), and normal leukocyte counts (56.9%). Other findings included abnormal levels of liver function (39.8%), elevated procalcitonin (36.6%), leukocytosis (21.7%), thrombocytopenia (19.0%), and leucopenia (18.2%). Most patients showed acute respiratory distress syndrome (60.8%). Other complications included acute cardiac injury (37.1%), shock (32.0%), and acute kidney injury (22.0%). The most common symptoms of severe or critically ill COVID-19 patients were fever and cough. Most patients showed lymphopenia, elevated levels of C-reactive protein and D-dimer. A large percentage of patients progress to ARDS, acute cardiac injury, acute kidney injury and shock were also common.
- 24 July 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (2) , 962-972
Coagulation dysfunction is associated with severity of COVID‐19: A meta‐analysis
To systematically analyze the blood coagulation features of coronavirus disease 2019 (COVID‐19) patients to provide a reference for clinical practice. An electronic search in PubMed, EMbase, Web of Science, Scopus, CNKI, WanFang Data, and VIP databases to identify studies describing the blood coagulation features of COVID‐19 patients from 1 January 2020 to 21 April 2020. Three reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies, then, the meta‐analysis was performed by using Stata 12.0 software. Thirty‐four studies involving 6492 COVID‐19 patients were included. Meta‐analysis showed that patients with severe disease showed significantly lower platelet count (weighted mean differences [WMD]: −16.29 × 109/L; 95% confidence interval [CI]: −25.34 to −7.23) and shorter activated partial thromboplastin time (WMD: −0.81 seconds; 95% CI: −1.94 to 0.33) but higher D‐dimer levels (WMD: 0.44 μg/mL; 95% CI: 0.29‐0.58), higher fibrinogen levels (WMD: 0.51 g/L; 95% CI: 0.33‐0.69) and longer prothrombin time (PT; WMD: 0.65 seconds; 95% CI: 0.44‐0.86). Patients who died showed significantly higher D‐dimer levels (WMD: 6.58 μg/mL; 95% CI: 3.59‐9.57), longer PT (WMD: 1.27 seconds; 95% CI: 0.49‐2.06) and lower platelet count (WMD: −39.73 × 109/L; 95% CI: −61.99 to −17.45) than patients who survived. Coagulation dysfunction is common in severe COVID‐19 patients and it is associated with severity of COVID‐19.
- 24 July 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (2) , 962-972
Coagulation dysfunction is associated with severity of COVID‐19: A meta‐analysis
To systematically analyze the blood coagulation features of coronavirus disease 2019 (COVID‐19) patients to provide a reference for clinical practice. An electronic search in PubMed, EMbase, Web of Science, Scopus, CNKI, WanFang Data, and VIP databases to identify studies describing the blood coagulation features of COVID‐19 patients from 1 January 2020 to 21 April 2020. Three reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies, then, the meta‐analysis was performed by using Stata 12.0 software. Thirty‐four studies involving 6492 COVID‐19 patients were included. Meta‐analysis showed that patients with severe disease showed significantly lower platelet count (weighted mean differences [WMD]: −16.29 × 109/L; 95% confidence interval [CI]: −25.34 to −7.23) and shorter activated partial thromboplastin time (WMD: −0.81 seconds; 95% CI: −1.94 to 0.33) but higher D‐dimer levels (WMD: 0.44 μg/mL; 95% CI: 0.29‐0.58), higher fibrinogen levels (WMD: 0.51 g/L; 95% CI: 0.33‐0.69) and longer prothrombin time (PT; WMD: 0.65 seconds; 95% CI: 0.44‐0.86). Patients who died showed significantly higher D‐dimer levels (WMD: 6.58 μg/mL; 95% CI: 3.59‐9.57), longer PT (WMD: 1.27 seconds; 95% CI: 0.49‐2.06) and lower platelet count (WMD: −39.73 × 109/L; 95% CI: −61.99 to −17.45) than patients who survived. Coagulation dysfunction is common in severe COVID‐19 patients and it is associated with severity of COVID‐19.
- Open Access
- 21 April 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (7) , 891-902
CT imaging features of 4121 patients with COVID‐19: A meta‐analysis
Objective We systematically reviewed the CT imaging features of COVID‐19 in order to provide reference for clinical practice. Methods Our article comprehensively searched PubMed, FMRS, EMbase, CNKI,WanFang databases and VIP databases to collect literatures about the CT imaging features of COVID‐19 from 1 January 2020 to 16 March 2020. Three reviewers independently screened literature, extracted data and assessed the risk of bias of included studies, and then, this meta‐analysis was performed by using Stata12.0 software. Results 34 retrospective studies involving a total of 4 121 COVID‐19 patients were included. The results of meta‐analysis showed that most patients presented bilateral lung involvement (73.8%, 95%CI: 65.9%‐81.1%) or multilobar involvement (67.3%,95%CI: 54.8%‐78.7 %) and just a little patients showed normal CT findings (8.4%). We found that the most common changes in lesion density was ground‐glass opacities (68.1%,95%CI: 56.9%‐78.2%). Other changes in density included air bronchogram sign(44.7%), crazy‐paving pattern (35.6%) and consolidation (32.0%). Patchy (40.3%), spider web sign (39.5%), cord‐like (36.8%) and nodular (20.5%) were common lesion shapes in COVID‐19 patients. Pleural thickening (27.1%) was found in some patients. Lymphadenopathy(5.4%) and pleural effusion (5.3%) were rare. Conclusion The lung lesions of patients with COVID‐19 were mostly bilateral lungs or multilobar involved. The most common chest CT findings were patchy and ground‐glass opacities. Some patients had air bronchogram, spider web sign and cord‐like. Lymphadenopathy and pleural effusion were rare.
- 21 April 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (7) , 891-902
Open AccessCT imaging features of 4121 patients with COVID‐19: A meta‐analysis
Objective We systematically reviewed the CT imaging features of COVID‐19 in order to provide reference for clinical practice. Methods Our article comprehensively searched PubMed, FMRS, EMbase, CNKI,WanFang databases and VIP databases to collect literatures about the CT imaging features of COVID‐19 from 1 January 2020 to 16 March 2020. Three reviewers independently screened literature, extracted data and assessed the risk of bias of included studies, and then, this meta‐analysis was performed by using Stata12.0 software. Results 34 retrospective studies involving a total of 4 121 COVID‐19 patients were included. The results of meta‐analysis showed that most patients presented bilateral lung involvement (73.8%, 95%CI: 65.9%‐81.1%) or multilobar involvement (67.3%,95%CI: 54.8%‐78.7 %) and just a little patients showed normal CT findings (8.4%). We found that the most common changes in lesion density was ground‐glass opacities (68.1%,95%CI: 56.9%‐78.2%). Other changes in density included air bronchogram sign(44.7%), crazy‐paving pattern (35.6%) and consolidation (32.0%). Patchy (40.3%), spider web sign (39.5%), cord‐like (36.8%) and nodular (20.5%) were common lesion shapes in COVID‐19 patients. Pleural thickening (27.1%) was found in some patients. Lymphadenopathy(5.4%) and pleural effusion (5.3%) were rare. Conclusion The lung lesions of patients with COVID‐19 were mostly bilateral lungs or multilobar involved. The most common chest CT findings were patchy and ground‐glass opacities. Some patients had air bronchogram, spider web sign and cord‐like. Lymphadenopathy and pleural effusion were rare.